The Valley Desk

ArticleClinical advances in hematology & oncology : H&OPublished

Improving outcomes in pediatric NTRK gene fusion-positive solid tumors: importance of genomic testing and targeted therapy with the TRK inhibitor larotrectinib

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Clinical advances in hematology & oncology : H&O
Published
Subject terms
Humans; Neoplasms; Pyrazoles; Pyrimidines; Pyrroles; Receptor, trkA; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Treatment Outcome; Child; Molecular Targeted Therapy
PubMed ID
38739704
Added to directory
Source checked

Report a correction or request removal